Table 2.

Metastases characteristics

		Metastases
		n	%
Total		358
Median follow-up (months)		3.8
Median dose (Gy)(range)	20 (12-24)
Size	<2 cm	289	80.7%
	2 to 3 cm	52	14.5%
	>3 cm	17	4.7%
Pre-tx hemorrhage
	Yes	78	21.8%
	No	270	75.4%
	Unknown	10	2.8%
Post-tx hemorrhage
	Yes	74	20.7%
	No	284	79.3%
Local failures		79	22.1%
Response to local failures	Crani	30	38.0%
	WBRT	9	11.4%
	Re-SRS	7	8.9%
	Supportive	33	41.8%
Response to post-treatment hemorrhage	Crani	15	20.3%
	WBRT	4	5.4%
	Re-SRS	1	1.4%
	Supportive	54	73.0%